{"id":10318,"date":"2023-03-06T07:00:00","date_gmt":"2023-03-06T06:00:00","guid":{"rendered":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/"},"modified":"2023-03-06T07:00:00","modified_gmt":"2023-03-06T06:00:00","slug":"irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023","status":"publish","type":"mfn_news","link":"https:\/\/irlab.se\/sv\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/","title":{"rendered":"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023"},"content":{"rendered":"

[mfn_before_post]<\/p>\n

\n

G\u00f6teborg, Sverige, 6 mars 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelade idag att bolaget presenterar p\u00e5 AGBSC Investor Day som h\u00e5lls p\u00e5 onsdag den 8 mars 2023 i Stockholm.<\/strong><\/p>\n<\/div>\n

\n

Nicholas Waters, EVP och HEAD of R&D, och Viktor Siewertz, CFO, kommer att delta p\u00e5 eventet. Bolaget presenteras kl. 11:15-11:45 den 8 mars 2023. Detta \u00e4r ett event som h\u00e5lls p\u00e5 Haymarket by Scandic, H\u00f6torget 13-15, Stockholm, samt lives\u00e4nds.<\/p>\n

Mer information kan hittas p\u00e5 eventets hemsida: https:\/\/cr.abgsc.com\/artiklar\/2023\/02\/abgsc-investor-days-7-8-march\/<\/a>.<\/p>\n<\/div>\n

\n

F\u00f6r mer information<\/strong><\/p>\n

\n

Gunnar Olsson, VD
Tel: +46 70 576 14 02
E-post: gunnar.olsson@irlab.se<\/a><\/p>\n

Viktor Siewertz, CFO
Tel: +46 727 10 70 70
E-post:\u00a0viktor.siewertz@irlab.se<\/a><\/p>\n<\/div>\n

\n

Om IRLAB<\/strong><\/p>\n

\n

IRLAB uppt\u00e4cker och utvecklar nya l\u00e4kemedel f\u00f6r behandling av Parkinsons sjukdom och andra sjukdomar i hj\u00e4rnan. Bolagets l\u00e4ngst framskridna l\u00e4kemedelskandidater, mesdopetam (IRL790) och pirepemat (IRL752) \u00e4r b\u00e5da i Fas IIb och \u00e4r designade f\u00f6r att behandla n\u00e5gra av de sv\u00e5raste symtomen relaterade till Parkinson. \u00c5r 2021 f\u00f6rv\u00e4rvade Ipsen, ett specialty pharma-bolag, de exklusiva globala r\u00e4ttigheterna till utveckling och kommersialisering av mesdopetam.
\u00a0
IRLAB har genererat alla sina l\u00e4kemedelskandidater och forts\u00e4tter att uppt\u00e4cka innovativa l\u00e4kemedelskandidater f\u00f6r behandling av neurologiska sjukdomar genom den egenutvecklade forskningsplattformen ISP (Integrative Screening Process). F\u00f6rutom IRLAB:s starka kliniska pipeline driver bolaget tre prekliniska program, IRL942, IRL757 och IRL1117, mot Fas I-studier. IRLAB \u00e4r noterat p\u00e5 Nasdaq Stockholm. Mer information p\u00e5\u00a0www.irlab.se.<\/a><\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023<\/a><\/p>\n<\/div>\n

[mfn_after_post]<\/p>\n","protected":false},"excerpt":{"rendered":"

G\u00f6teborg, Sverige, 6 mars 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelade idag att bolaget presenterar p\u00e5 AGBSC Investor Day som h\u00e5lls p\u00e5 onsdag den 8 mars 2023 i Stockholm.<\/p>\n","protected":false},"template":"","class_list":["post-10318","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nIRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023 - IRLAB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023 - IRLAB\" \/>\n<meta property=\"og:description\" content=\"G\u00f6teborg, Sverige, 6 mars 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelade idag att bolaget presenterar p\u00e5 AGBSC Investor Day som h\u00e5lls p\u00e5 onsdag den 8 mars 2023 i Stockholm.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"IRLAB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/\",\"url\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/\",\"name\":\"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023 - IRLAB\",\"isPartOf\":{\"@id\":\"https:\/\/irlab.se\/#website\"},\"datePublished\":\"2023-03-06T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/irlab.se\/sv\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\/\/irlab.se\/sv\/pressmeddelanden\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/irlab.se\/#website\",\"url\":\"https:\/\/irlab.se\/\",\"name\":\"Irlab\",\"description\":\"Novel treatments for Parkinson's disease\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/irlab.se\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023 - IRLAB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/","og_locale":"sv_SE","og_type":"article","og_title":"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023 - IRLAB","og_description":"G\u00f6teborg, Sverige, 6 mars 2023 \u2013 IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), ett bolag som uppt\u00e4cker och utvecklar nya behandlingar vid Parkinsons sjukdom, meddelade idag att bolaget presenterar p\u00e5 AGBSC Investor Day som h\u00e5lls p\u00e5 onsdag den 8 mars 2023 i Stockholm.","og_url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/","og_site_name":"IRLAB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/","url":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/","name":"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023 - IRLAB","isPartOf":{"@id":"https:\/\/irlab.se\/#website"},"datePublished":"2023-03-06T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/irlab.se\/mfn_news\/irlab-presenterar-pa-abgsc-investor-day-i-stockholm-den-8-mars-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/irlab.se\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/irlab.se\/sv\/pressmeddelanden\/"},{"@type":"ListItem","position":3,"name":"IRLAB presenterar p\u00e5 ABGSC Investor Day i Stockholm den 8 mars 2023"}]},{"@type":"WebSite","@id":"https:\/\/irlab.se\/#website","url":"https:\/\/irlab.se\/","name":"Irlab","description":"Novel treatments for Parkinson's disease","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/irlab.se\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"}]}},"_links":{"self":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news\/10318","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/irlab.se\/sv\/wp-json\/wp\/v2\/media?parent=10318"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}